Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Pectinase-Processed Ginseng Radix (GINST) Ameliorates Hyperglycemia and Hyperlipidemia in High Fat Diet-Fed ICR Mice

  • Yuan, Hai-Dan (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University) ;
  • Kim, Jung-Tae (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University) ;
  • Chung, Sung-Hyun (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University)
  • Received : 2011.09.19
  • Accepted : 2011.12.12
  • Published : 2012.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

To develop a ginseng product possessing an efficacy for diabetes, ginseng radix ethanol extract was treated with pectinase and obtained the GINST. In the present study, we evaluate the beneficial effect of GINST on high fat diet (HFD)-induced hyperglycemia and hyperlipidemia and action mechanism(s) in ICR mice. The mice were randomly divided into five groups: regular diet group (RD), high fat diet group (HFD), HFD plus GINST at 75 mg/kg (GINST75), 150 mg/kg (GINST150), and 300 mg/kg (GINST300). Oral glucose tolerance test reveals that GINST improves the glucose tolerance after glucose challenge. Fasting plasma glucose and insulin levels were decreased by 4.3% and 4.2% in GINST75, 10.9% and 20.0% in GINST150, and 19.6% and 20.9% in GINST300 compared to those in HFD control group. Insulin resistance indices were also markedly decreased by 8.2% in GINST75, 28.7% in GINST150, and 36.4% in GINST300, compared to the HFD control group. Plasma triglyceride, total cholesterol and non-esterified fatty acid levels in the GINST300 group were decreased by 13.5%, 22.7% and 24.1%, respectively, compared to those in HFD control group. Enlarged adipocytes of HFD control group were markedly decreased in GINST-treated groups, and shrunken islets of HFD control mice were brought back to near normal shape in GINST300 group. Furthermore, GINST enhanced phosphorylation of AMP-activated protein kinase (AMPK) and glucose transporter 4 (GLUT4). In summary, GINST prevents HFD-induced hyperglycemia and hyperlipidemia through reducing insulin resistance via activating AMPK-GLUT4 pathways, and could be a potential therapeutic agent for type 2 diabetes.

Keywords

References

  1. Chiang, C. K., Ho, T. I., Peng, Y. S., Hsu, S. P., Pai. M. F., Yang, S. Y., Hung, K. Y. and Wu, K. D. (2007) Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects. Diabetes Care 30, 3-7. https://doi.org/10.2337/dc06-0956
  2. Choi, K., Kim, M., Ryu, J. and Choi, C. (2007) Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci. Lett. 421, 37-41. https://doi.org/10.1016/j.neulet.2007.05.017
  3. Cusi, K. (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr. Diab. Rep. 10, 306-315. https://doi.org/10.1007/s11892-010-0122-6
  4. Egawa, T., Hamada, T., Ma, X., Karaike, K., Kameda, N., Masuda, S., Iwanaka, N. and Hayashi, T. (2011) Caffeine activates preferentially $\alpha$1-isoform of 5'AMP-activated protein kinase in rat skeletal muscle. Acta. Physiol (Oxf). 201, 227-238. https://doi.org/10.1111/j.1748-1716.2010.02169.x
  5. Furugen, A., Kobayashi, M., Narumi, K., Watanabe, M., Otake, S., Itagaki, S. and Iseki, K. (2011) AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle. Life Sci. 88, 163-168. https://doi.org/10.1016/j.lfs.2010.11.003
  6. Han, G. C., Ko, S. K., Sung, J. H. and Chung, S. H. (2007) Compound K enhances insulin secretion with benefi cial metabolic effects in db/ db mice. J. Agric. Food Chem. 55, 10641-10648. https://doi.org/10.1021/jf0722598
  7. Kim, Y. M., Namkoong, S., Yun, Y. G., Hong, H. D., Lee, Y. C., Ha, K. S., Lee, H., Kwon, H. J., Kwon, Y. G. and Kim, Y. M. (2007) Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol. Pharm. Bull. 30, 1674- 1679. https://doi.org/10.1248/bpb.30.1674
  8. Kim, D., Y., Yuan, H. D., Chung, I. K. and Chung, S. H. (2009) Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J. Agric. Food Chem. 57, 1532-1537. https://doi.org/10.1021/jf802867b
  9. Kobayashi, M., Iwata, M. and Haruta, T. (2000) Clinical evaluation of pioglitazone. Nihon Rinsho 58, 395-400.
  10. Lee, S. J., Ko, W. G., Kim, J. H., Sung, J.H., Moon, C. K. and Lee, B. H. (2000) Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase- 3 protease. Biochem. Pharmacol. 60, 677-685. https://doi.org/10.1016/S0006-2952(00)00362-2
  11. Liao, Z., Chen, X. and Wu, M. (2010) Antidiabetic effect of fl avones from Cirsium japonicum DC in diabetic rats. Arch. Pharm. Res. 33, 353-362. https://doi.org/10.1007/s12272-010-0302-6
  12. Liu, X. Q., Wu, L. and Guo, X. J. (2009) Effect of Bu-Zhong-Yi-Qi-Tang on defi ciency of N-glycan/nitric oxide and islet damage induced by streptozotocin in diabetic rats. World J. Gastroenterol. 15, 1730- 1737. https://doi.org/10.3748/wjg.15.1730
  13. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28, 412-419. https://doi.org/10.1007/BF00280883
  14. Musi, N. and Goodyear, L. J. (2003) AMP-activated protein kinase and muscle glucose uptake. Acta. Physiol. Scand. 178, 337-345. https://doi.org/10.1046/j.1365-201X.2003.01168.x
  15. Niswender, K. (2010) Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes Obes. Metab. 12, 267-287. https://doi.org/10.1111/j.1463-1326.2009.01175.x
  16. Ryder, J. W., Chibalin, A. V. and Zierath, J. R. (2001) Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol. Scand. 171, 249-257. https://doi.org/10.1046/j.1365-201x.2001.00827.x
  17. Stades, A. M., Heikens, J. T., Erkelens, D. W., Holleman, F. and Hoekstra, J. B. (2004) Metformin and lactic acidosis: cause or coincidence? A review of case reports. J. Intern. Med. 255, 179-187. https://doi.org/10.1046/j.1365-2796.2003.01271.x
  18. Steinberg, G. R. and Jorgensen, S. B. (2007) The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev. Med. Chem. 7, 519-526.
  19. Tuttle, K. R., McGill, J. B., Haney, D. J., Lin, T. E. and Anderson, P. W.; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups. (2007) Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease. Clin. J. Am. Soc. Nephrol. 2, 631-636. https://doi.org/10.2215/CJN.00840207
  20. Warren, R. E. (2004) The stepwise approach to the management of type 2 diabetes. Diabetes. Res. Clin. Pract. 65(Suppl 1), S3-8. https://doi.org/10.1016/j.diabres.2004.07.002
  21. Yamamoto, E., Nakamura, T., Kataoka, K., Tokutomi, Y., Dong, Y. F., Fukuda, M., Nako, H., Yasuda, O., Ogawa, H. and Kim-Mitsuyama, S. (2010) Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochem. Biophys. Res. Commun. 403, 258-263. https://doi.org/10.1016/j.bbrc.2010.11.008
  22. Yoon, S. H., Han, E. J., Sung, J. H. and Chung, S. H. (2007) Anti-diabetic effects of compound K versus metformin versus compound Kmetformin combination therapy in diabetic db/db mice. Biol. Pharm. Bull. 30, 2196-2200. https://doi.org/10.1248/bpb.30.2196
  23. Yuan, H. D., Kim, S. J. and Chung, S. H. (2011) Benefi cial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol- 3 kinase pathways. Metabolism 60, 43-51. https://doi.org/10.1016/j.metabol.2009.12.024
  24. Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M. and Kambadur, R. (2011) Myostatin- defi cient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 54, 1491-1501. https://doi.org/10.1007/s00125-011-2079-7
  25. Zhu, C. F., Peng, .H B., Liu, G. Q., Zhang, F. and Li, Y. (2010) Benefi - cial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes. Nutrition 26, 1014-1020. https://doi.org/10.1016/j.nut.2010.01.011

Cited by

  1. Ginseng and obesity 2017, https://doi.org/10.1016/j.jgr.2016.12.005
  2. An 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract vol.38, pp.4, 2014, https://doi.org/10.1016/j.jgr.2014.05.006
  3. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models vol.5, pp.119, 2015, https://doi.org/10.1039/C5RA20559J
  4. Antidiabetic plants improving insulin sensitivity vol.66, pp.9, 2014, https://doi.org/10.1111/jphp.12243
  5. Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial vol.36, pp.5, 2016, https://doi.org/10.1016/S0254-6272(16)30084-X
  6. Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice vol.13, pp.8, 2018, https://doi.org/10.1371/journal.pone.0202910
  7. 고려인삼과 당뇨병: 세포와 동물 및 인체실험을 통한 고려인삼의 당뇨병에 대한 효능 vol.51, pp.1, 2012, https://doi.org/10.22889/kjp.2020.51.1.001
  8. One-Pot Process for the Production of Ginsenoside Rd by Coupling Enzyme-Assisted Extraction with Selective Enzymolysis vol.43, pp.10, 2012, https://doi.org/10.1248/bpb.b19-01127
  9. The effects of ginseng on the metabolic syndrome: An updated review vol.9, pp.9, 2021, https://doi.org/10.1002/fsn3.2475